These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6282198)

  • 1. Serum bactericidal activity of moxalactam and cefotaxime with and without tobramycin against Pseudomonas aeruginosa and Staphylococcus aureus.
    Lagast H; Zinner SH; Klastersky J
    Antimicrob Agents Chemother; 1981 Oct; 20(4):539-41. PubMed ID: 6282198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative synergistic activity of cefoperazone, cefotaxime, moxalactam, and carbenicillin, combined with tobramycin, against Pseudomonas aeruginosa.
    Mintz L; Drew WL
    Antimicrob Agents Chemother; 1981 Feb; 19(2):332-4. PubMed ID: 6289731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procedure for assay of tobramycin in serum containing moxalactam.
    Mahoney DF; Butler TF; Turner JR
    Antimicrob Agents Chemother; 1981 May; 19(5):934-6. PubMed ID: 6457559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moxalactam-tobramycin-resistant Pseudomonas aeruginosa isolates in patients with cystic fibrosis.
    Fitzpatrick SB; Rosenstein BJ
    Clin Pediatr (Phila); 1983 Sep; 22(9):628-30. PubMed ID: 6224623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of cefoperazone, cefotaxime, and moxalactam (LY127935) against aerobic gram-negative bacilli.
    Lang SD; Edwards DJ; Durack DT
    Antimicrob Agents Chemother; 1980 Mar; 17(3):488-93. PubMed ID: 6252831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moxalactam (LY127935), a new semisynthetic 1-oxa-beta-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycin.
    Jones RN; Fuchs PC; Sommers HM; Gavan TL; Barry AL; Gerlach EH
    Antimicrob Agents Chemother; 1980 Apr; 17(4):750-6. PubMed ID: 6446880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of serum bactericidal activity after administration of cefoperazone, cefotaxime, ceftizoxime, and moxalactam to healthy subjects.
    Barriere SL; Ozasa DC; Mordenti J
    Antimicrob Agents Chemother; 1985 Jul; 28(1):55-7. PubMed ID: 3929680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial activity of moxalactam (LY-127935) compared with cefotaxime and other beta-lactam antibiotics against clinical isolates of enterobacteriacea and non-fermenters.
    Verbist L
    Arzneimittelforschung; 1981; 31(6):982-6. PubMed ID: 6266430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of predicted serum bactericidal activities and values measured in volunteers.
    Drusano G; Standiford H; Ryan P; McNamee W; Tatem B; Schimpff S
    Eur J Clin Microbiol; 1986 Feb; 5(1):88-92. PubMed ID: 3084247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bactericidal and synergistic activity of moxalactam alone and in combination with gentamicin against Pseudomonas aeruginosa.
    Yu PK; Edson RS; Washington JA; Hermans PE
    Antimicrob Agents Chemother; 1983 Jan; 23(1):179-81. PubMed ID: 6219619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of moxalactam and gentamicin: in-vitro study with strains of Staphylococcus aureus and Pseudomonas aeruginosa.
    Skalova R; Hajsig D; Smerdel S
    J Antimicrob Chemother; 1982 Feb; 9(2):103-9. PubMed ID: 6460731
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of inoculum size on activity of cefoperazone, cefotaxime, moxalactam, piperacillin, and N-formimidoyl thienamycin (MK0787) against Pseudomonas aeruginosa.
    Corrado ML; Landesman SH; Cherubin CE
    Antimicrob Agents Chemother; 1980 Dec; 18(6):893-6. PubMed ID: 6263178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)].
    Nasnas R; Gutmann L; Kitzis MD; Goldstein F; Acar JF
    Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of serum bactericidal activity of cefotaxime alone or in combination with tobramycin.
    Bergeron MG; LeBel M; Charest A; Forcier JF; Morin J; Vallée F
    Antimicrob Agents Chemother; 1986 Feb; 29(2):379-81. PubMed ID: 3087282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of gram-positive cocci to various antibiotics, including cefotaxime, moxalactam, and N-formimidoyl thienamycin.
    Cherubin CE; Corrado ML; Sierra MF; Gombert ME; Shulman M
    Antimicrob Agents Chemother; 1981 Oct; 20(4):553-5. PubMed ID: 6282200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.
    Giamarellou H
    Am J Med; 1986 Jun; 80(6B):126-37. PubMed ID: 3088998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The serum bactericidal activity of latamoxef (moxalactam), cefoperazone and cefotaxime.
    McNamee W; Drusano GL; Tatem BA; Standiford HC
    J Antimicrob Chemother; 1984 Nov; 14(5):491-7. PubMed ID: 6096348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum bactericidal test in volunteers--a review.
    Schimpff SC; Drusano GL; Standiford HC
    Eur J Clin Microbiol; 1986 Feb; 5(1):71-8. PubMed ID: 3084246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ceftriaxone on Pseudomonas aeruginosa and Staphylococcus aureus in broth, serum, and in combination with human polymorphonuclear leukocytes.
    Bassler M; Blaschke H; Just M; Daschner FD
    Chemotherapy; 1982; 28(5):390-6. PubMed ID: 6291868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in vitro studies of Ro 13-9904, a new cephalosporin derivative.
    Eickhoff TC; Ehret J
    Antimicrob Agents Chemother; 1981 Mar; 19(3):435-42. PubMed ID: 6264845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.